Principles of cerebral perfusion imaging by bolus tracking

Journal of Magnetic Resonance Imaging

Volumn 22, Issue 6, 2005, Pages 710-717

  Østergaard, Leif ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cerebral blood flow; Cerebral perfusion imaging; Deconvolution; Dynamic susceptibility contrast; Perfusion methodology

Indexed keywords

TRACER;

BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CALCULATION; CONFERENCE PAPER; DYNAMIC SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE IMAGING; FLOW KINETICS; FOURIER DECONVOLUTION; HEMODYNAMICS; HUMAN; IMAGE ANALYSIS; MEAN TRANSIT TIME; MEASUREMENT; MICROVASCULATURE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PRIORITY JOURNAL; SIGNAL DETECTION; SINGULAR VALUE DECOMPOSITION; STATISTICAL MODEL; TECHNIQUE; THEORETICAL MODEL;

BLOOD VOLUME; CEREBROVASCULAR CIRCULATION; HEMODYNAMIC PROCESSES; HUMANS; MAGNETIC RESONANCE IMAGING; MICROCIRCULATION; MODELS, THEORETICAL;

EID: 28444463228     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20460     Document Type: Conference Paper

References (48)

1. Calamante F, Thomas DL, Pell GS, Wiersma J, Turner R. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab 1999;19:701-735.
2. Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects. Magn Reson Med 1988;6:164-174.
3. Fisel CR, Ackerman JL, Buxton RB, et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991;17:336-347.
4. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555-566.
5. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994;31:601-610.
6. Østergaard L, Smith DF, Vestergaard-Poulsen P, et al. Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values. J Cereb Blood Flow Metab 1998;18:425-432.
7. Simonsen CZ, Østergaard L, Vestergaard-Poulsen P, Rohl L, Bjornerud A, Gyldensted C. CBF and CBV measurements by USPIO bolus tracking: reproducibility and comparison with Gd-based values. J Magn Reson Imaging 1999;9:342-347.
8. Kiselev VG, Posse S. Analytical theory of susceptibility induced NMR signal dephasing in a cerebrovascular network. Phys Rev Lett 1998;81:5696-5699.
9. Kiselev VG, Posse S. Analytical model of susceptibility-induced MR signal dephasing: effect of diffusion in a microvascular network. Magn Reson Med 1999;41:499-509.
10. Kiselev VG. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn Reson Med 2001;46: 1113-1122.
11. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-265.
12. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-299; see discussion, pp. 300-293.
13. Rosen BR, Belliveau JW, Buchbinder BR, et al. Contrast agents and cerebral hemodynamics. Magn Reson Med 1991;19:285-292.
14. Belliveau JW, Kennedy Jr DN, McKinstry RC, et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 1991;254:716-719.
15. Stewart GN. Researches on the circulation time in organs and on the influences which affect it. Parts I-III. J Physiol (London) 1894; 15:1-89.
16. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954;6: 731-744.
17. Zierler KL. Equations for measuring blood flow by external monitoring of radioisotopes. Circ Res 1965;16:309-321.
18. Zierler KL. Theoretical basis of indicator-dilution methods for measuring flow and volume. Circ Res 1962;10:393-407.
19. Thompson Jr HK, Starmer CF, Whalen RE, McIntosh HD. Indicator transit time considered as a gamma variate. Circ Res 1964;14:502-515.
20. Perkio J, Aronen HJ, Kangasmaki A, et al. Evaluation of four post-processing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Magn Reson Med 2002;47:973-981.
21. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637-641.
22. Gobbel GT, Fike JR. A deconvolution method for evaluating indicator-dilution curves. Phys Med Biol 1994;39:1833-1854.
23. Van Huffel S, Vandewalle J, De Roo MC, Willems JL. Reliable and efficient deconvolution technique based on total linear least squares for calculating the renal retention function. Med Biol Eng Comput 1987;25:26-33.
24. Bronikowski TA, Dawson CA, Linehan JH. Model-free deconvolution techniques for estimating vascular transport functions. Int J Biomed Comput 1983;14:411-429.
25. Liu HL, Pu Y, Liu Y, et al. Cerebral blood flow measurement by dynamic contrast MRI using singular value decomposition with an adaptive threshold. Magn Reson Med 1999;42:167-172.
26. Østergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I. Mathematical approach and Statistical analysis. Magn Reson Med 1996;36:715-725.
27. Alsop D, Schlaug G. The equivalence of SVD and Fourier deconvolution for dynamic susceptibility contrast analysis. In: Proceedings of the 9th Annual Meeting of ISMRM, Glasgow. Scotland, 2001. p 1581.
28. Smith AM, Grandin CB, Duprez T, Mataigne F, Cosnard G. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients. J Magn Reson Imaging 2000;12: 400-410.
29. Wirestam R, Andersson L, Østergaard L, et al. Assessment of regional cerebral blood flow by dynamic susceptibility contrast MRI using different deconvolution techniques. Magn Reson Med 2000; 43:691-700.
30. Wu O, Østergaard L, Koroshetz WJ, et al. Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med 2003;50:856-864.
31. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000;44:466-473.
32. Wu O, Østergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 2003;50:164-174.
33. Larson KB, Perman WH, Perlmutter JS, Gado MH, Ollinger JM, Zierler K. Tracer-kinetic analysis for measuring regional cerebral blood flow by dynamic nuclear magnetic resonance imaging. J Theor Biol 1994;170:1-14.
34. Østergaard L, Chesler DA, Weisskoff RM, Sorensen AG, Rosen BR. Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data. J Cereb Blood Flow Metab 1999;19:690-699.
35. King RB, Deussen A, Raymond GM, Bassingthwaighte JB. A vascular transport operator. Am J Physiol 1993;265:H2196-H2208.
36. King RB, Raymond GM, Bassingthwaighte JB. Modeling blood flow heterogeneity. Ann Biomed Eng 1996;24:352-372.
37. Vonken EJ, van Osch MJ, Bakker CJ, Viergever MA. Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J Magn Reson Imaging 1999; 10:109-117.
38. Vonken EP, Beekman FJ, Bakker CJ, Viergever MA. Maximum likelihood estimation of cerebral blood flow in dynamic susceptibility contrast MRI. Magn Reson Med 1999;41:343-350.
39. Andersen IK, Szymkowiak A, Rasmussen CE, et al. Perfusion quantification using Gaussian process deconvolution. Magn Reson Med 2002;48:351-361.
40. Lassen NA. Cerebral transit of an intravascular tracer may allow measurement of regional blood volume but not regional blood flow. J Cereb Blood Flow Metab 1984;4:633-634.
41. Weisskoff RM, Chesler D, Boxerman JL, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;29:553-558.
42. Schreiber WG, Guckel F, Stritzke P, Schmiedek P, Schwartz A, Brix G. Cerebral blood flow and cerebrovascular reserve capacity: estimation by dynamic magnetic resonance imaging. J Cereb Blood Flow Metab 1998;18:1143-1156.
43. Østergaard L, Johannsen P, Host-Poulsen P, et al. Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [(15)O]H2O positron emission tomography in humans. J Cereb Blood Flow Metab 1998;18:935-940.
44. Alsop DC, Wedmid A, Schlaug G. Defining a local input function for perfusion quantification with bolus contrast MRI. In: Proceedings of the 10th Annual Meeting of ISMRM, Honolulu, 2002. p 659.
45. Crone C. The permeability of capillaries in various organs as determined by use of the 'indicator diffusion' method. Acta Physiol Scand 1963;58:292-305.
46. Renkin EM. Exchangeability of tissue potassium in skeletal muscle. Am J Physiol 1959;197:1211-1215.
47. Shih LC, Saver JL, Alger JR, et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003;34:1425-1430.
48. Yamada K, Wu O, Gonzalez RG, et al. Magnetic resonance perfusion-weighted imaging of acute cerebral infarction: effect of the calculation methods and underlying vasculopathy. Stroke 2002; 33:87-94.